Sulforaphane protects SK-N-SH cells against antipsychotic-induced oxidative stress

Antioxidant Therapeutics for Schizophrenia

(2010) Ravinder Reddy et al.   ANTIOXIDANTS & REDOX SIGNALING

Haloperidol causes cytoskeletal collapse in N1E-115 cells through tau hyperphosphorylation induced by oxidative stress: Implications for neurodevelopment

(2010) Gloria Benítez-King et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole

(2010) H G Shertzer et al.   INTERNATIONAL JOURNAL OF OBESITY

Antipsychotic Medication and Oxidative Cell Stress

(2010) Peter Lepping et al.   JOURNAL OF CLINICAL PSYCHIATRY

Clozapine Treatment Causes Oxidation of Proteins Involved in Energy Metabolism in Lymphoblastoid Cells: A Possible Mechanism for Antipsychotic- Induced Metabolic Alterations

(2010) Muhammad R. Baig et al.   Journal of Psychiatric Practice

Short Term Dietary Fish Oil Supplementation Improves Motor Deficiencies Related to Reserpine-Induced Parkinsonism in Rats

(2010) Raquel Cristine Silva Barcelos et al.   LIPIDS

Oxidative stress in schizophrenia: An integrated approach

(2010) Byron K.Y. Bitanihirwe et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics

(2010) Manuela Padurariu et al.   NEUROSCIENCE LETTERS

A meta-analysis of oxidative stress markers in schizophrenia

(2010) Ming Zhang et al.   Science China-Life Sciences

Antipsychotic-induced DRD2 upregulation and its prevention by α-lipoic acid in SH-SY5Y Neuroblastoma cells

(2010) Jessica Deslauriers et al.   SYNAPSE

Inhibitory effects of polyphenol compounds on lipid peroxidation caused by antipsychotics (haloperidol and amisulpride) in human plasmain vitro

(2010) Anna Dietrich-muszalska et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Protective role of selenium supplementation against cardiac lesions induced by the combination of levomepromazine and risperidone in the rabbit

(2009) W. Manati et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia

(2009) Vidhi Singh et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A Preliminary Investigation of α-Lipoic Acid Treatment of Antipsychotic Drug-Induced Weight Gain in Patients With Schizophrenia

(2009) Eosu Kim et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Comparing the Effects of High-Dose Vitamin E With Those of Placebo on Insulin Resistance in Patients With Schizophrenia Treated With Olanzapine

(2009) Fiona Baroyant Salmasi et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats

(2009) Santhrani Thaakur et al.   JOURNAL OF NEURAL TRANSMISSION

Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line

(2009) Andrea Tarozzi et al.   JOURNAL OF NEUROCHEMISTRY

Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures

(2009) Aubrey Siebert et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Oxidative stress, nitric oxide and prostaglandin E2levels in the gastrointestinal tract of aging rats

(2009) Frederic Mármol et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Sulforaphane improves cognitive function administered following traumatic brain injury

(2009) Pramod K. Dash et al.   NEUROSCIENCE LETTERS

Antipsychotic-induced oxidative stress in Rat Brain

(2009) MÁrcio R. Martins et al.   NEUROTOXICITY RESEARCH

Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients

(2009) Monia Raffa et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Lipid status, anti-oxidant enzyme defence and haemoglobin content in the blood of long-term clozapine-treated schizophrenic patients

(2009) Cedo Miljevic et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophrenia

(2009) OmPrakash Singh et al.   Indian Journal of Psychiatry

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

(2008) Michael Berk et al.   BIOLOGICAL PSYCHIATRY

Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality

(2008) J. McGrath et al.   EPIDEMIOLOGIC REVIEWS

Demonstration of an anti-oxidative stress mechanism of quetiapine

(2008) Haiyun Xu et al.   FEBS Journal

Clozapine causes oxidation of proteins involved in energy metabolism: a possible mechanism for antipsychotic-induced metabolic alterations

(2008) Consuelo Walss-Bass et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Impact of haloperidol and quetiapine on the expression of genes encoding antioxidant enzymes in human neuroblastoma SH-SY5Y cells

(2008) Andreas Johannes Schmidt et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Roles of Glutathione (GSH) in Dopamine (DA) Oxidation Studied by Improved Tandem HPLC Plus ESI-MS

(2008) Zhi Dong Zhou et al.   NEUROCHEMICAL RESEARCH

Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels

(2008) Mahendra Bishnoi et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain

(2007) M BISHNOI et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR